PPARG and non-small cell lung carcinoma: At last, Our research revealed that PPARG was the most significant transcriptional regulatory approach by enrichment analysis based on the TRRUST database, a case-control study shows that PPARG c.1347 C > T polymorphism was associated with risk of NSCLC [28].